Pune, Nov. 09, 2020 (GLOBE NEWSWIRE) -- The global dermatitis drugs market size will expand considerably in the coming years driven by the advancements across numerous drug classes. According to a report published by Fortune Business Insights, titled “Dermatitis Drugs: Global Market Analysis, Insights And Forecast, 2019-2026,” the market was valued at US$ 6,097.4 Mn in 2018. Fortune Business Insights predicts that the market will rise impressively at a CAGR of 10.2% and reach US$ 13,630.8 Mn by the end of 2026.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/dermatitis-drugs-market-100658
Topical Treatment for Atopic Dermatitis gets FDA Nod, Subsequently Aiding the Market’s Expansion
The global dermatitis drugs market will derive significant growth from increasing usage approvals. In 2017, the Food and Drug Administration passed approval for a new topical treatment for atopic dermatitis. The topical treatment ‘Eucrisa’ was aimed at the treatment of children and adults with mild to moderate atopic dermatitis. The use of Eucrisa to minimize the effects of dermatitis has fueled the demand for the products, across the world.
The ability of Eucrisa to act on a body enzyme ‘PDE4’ has created several benefits of the product and this, in turn, will lead to an increase in adoption. After successful clinical trials, Eucrisa was seen to reduce skin rashes, itching, and lichenification.
The applications of Eucrisa in the healthcare industry have had a positive impact on the global dermatitis drugs market and will favor the growth of the market in the coming years. Fortune Business Insights has predicted that growing usage approvals will bode well for the market in the near future.
Click here to get the short-term and long-term impact of COVID-19 on this Market.
Please visit: https://www.fortunebusinessinsights.com/industry-reports/dermatitis-drugs-market-100658
Increasing Mergers and Acquisitions Will Enable Growth
The global atopic dermatitis market will witness growth opportunities due to contributions from leading companies and their exceptional business strategies. Recent trends in dermatitis treatment include company mergers and acquisitions, aimed at the betterment of prevailing drugs and creating new drugs.
The growing mergers and acquisitions have boded well for the market and Fortune Business Insights has predicted that these activities will induce significant growth in the global dermatitis market in the coming years. In 2016, Pfizer announced that it plans to acquire Anacor Pharmaceuticals for an estimated US$ 5.2 Bn.
The company has splashed a huge amount for the take-over of Anacor and this is a strong indication of future growth. The report includes mergers and acquisition similar to the Pfizer-Anacor deal and gauges the impact of such M&As on the global dermatitis drugs market.
Quick Buy - Dermatitis Drugs Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/100658
Key companies covered in the Dermatitis Drugs Market report
- Valeant Pharmaceuticals
- Astellas Pharma US, Inc.
- Pfizer, Inc.
- Mylan
- Bayer AG
- Allergan
- LEO Pharma
- Regeneron Pharmaceuticals, Inc.
- Anacor Pharmaceuticals, Inc.
Segmentation of the Global Dermatitis Drugs Market:
Drug Class
• Calcineurin Inhibitors
• PDE4 Inhibitors
• Corticosteroids
• Biologics
• Others
By Disease Indication
• Atopic Dermatitis
• Contact Dermatitis
• Others
By Distribution Channel
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
By Geography
• North America (USA and Canada)
• Europe (UK, Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
• Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
• Rest of World
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/dermatitis-drugs-market-100658
SECONDARY RESEARCH IS CONDUCTED TO DERIVE THE FOLLOWING INFORMATION:
- Details such as revenues, market share, strategies, growth rate, product & their pricing by region/country for all major companies
- Details in relation to prevalence, incidence, patient numbers, distribution of patients, average price of treatment, etc.
- Number of end user facilities by region/country and average annual spending or procurement of devices by type of end user facility
- Number of procedures and average price of procedures
- Replacement rate and pricing of capital equipment
- Market dynamics in relation to the market under focus – Drivers, restraints, trends, and opportunities
- Market & technological trends, new product developments, product pipeline.
Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/dermatitis-drugs-market-100658
Have a Look at Related Reports:
Vitiligo Treatment Market Share and Global Trend By Treatment (Topical Treatment, Light Therapy, Surgical Procedures, Others), By Disease Type (Nonsegmental Vitiligo, Segmental Vitiligo), By End User (Hospitals, Aesthetic Clinics, Others) and Geography Forecast till 2026
Point of Care (POC) Diagnostics Market Share and Global Trend By Product (Blood Glucose Monitoring, Infectious Diseases, Cardiometabolic Diseases, Pregnancy and Fertility Testing Products, Hematology Testing Products, Others), By End User (Hospitals Bedside, Physician’s Office Lab, Urgent Care & Retail Clinics, Home and Self Testing) and Geography Forecast till 2026
Dermal Fillers Market Share and Global Trend By By Product (Biodegradable, Non-Biodegradable), By Ingredient (Hyaluronic Acid, Calcium Hydroxylapatite Poly-L-lactic Acid, PMMA (Poly (methyl methacrylate)), Fat Fillers), By Application (Scar Treatment, Wrinkle Correction Treatment, Lip Enhancement, Restoration of Volume/ Fullness) & Geography Forecast till 2026
Vitamin D Testing Market Share and Global Trend By Product (25 -Hydroxy Vitamin D Testing, 1,25-Dihydroxy Vitamin D Testing, 24,25-Dihydroxy Vitamin D Testing), By Application(Clinical Testing, Research Testing), By End User(Diagnostic Laboratories, Hospitals & Clinics) and Geography Forecast till 2026
Netherland Home healthcare Market Share and Global Trend By Product(Continence Care, Wound Care, Ostomy Care, Clinical Nutrition, Respiratory Care, Equipment & Housekeeping Supplies, Disposables) and Geography Forecast till 2026
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs
Press Release: https://www.fortunebusinessinsights.com/press-release/dermatitis-drugs-market-9139